Page 10 - Mrch Larsen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mrch larsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mrch Larsen Today - Breaking & Trending Today

Pfizer beats profit estimates on demand for new drugs, COVID products

Pfizer Inc on Tuesday beat estimates for first-quarter revenue and profit, helped by steady demand for its COVID products and reaffirmed its annual earnings forecast as it banks on newer drugs to contribute to growth later this year. ....

Bhanvi Satija , Sriraj Kalluvila , Raghav Mahobe , Pfizer Inc , Thomson Reuters Trust Principles , Thomson Reuters Trust , Rhpi Commercial Strategy , Rhpi Government Health Policy , Rhpi Public Health ,

Pfizer, BioNTech propose EU pays half for each cancelled COVID dose, Financial Times reports

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. ....

Bruxelles Capitale , Urvi Dugar , European Medicines Agency , Thomson Reuters Trust Principles , European Union , Pfizer Inc , Financial Times , Thomson Reuters Trust , Rhpi Public Health ,

AstraZeneca beats estimates on strong emerging market sales as COVID wanes

AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer drug Imfinzi and strong demand for its roster of drugs in emerging markets helped to offset dwindling COVID product sales. ....

City Of , United Kingdom , Natalie Grover , Pascal Soriot , Tomasz Janowski , Thomson Reuters Trust Principles , Maggie Fick Editing , Thomson Reuters Trust , Rhpi Commercial Strategy , Rhpi Government Health Policy , Rhpi Public Health ,

AbbVie's weak newer drug sales fan worries as Humira faces rivals

AbbVie Inc on Thursday missed quarterly revenue estimates for its newer treatments, fueling concerns over the drugmaker's attempts to cushion the blow to sales from fresh competition for its flagship arthritis drug Humira. ....

Sriraj Kalluvila , Evan Seigerman , Leroy Leo , Abbvie Inc , Thomson Reuters Trust Principles , Amgen Inc , Vie Inc , Botox Maker Allergan , Mariame Sunny , Thomson Reuters Trust , Rhpi Commercial Strategy , Rhpi Drug Device Trials ,